Immunovant Inc (IMVT)

NASDAQ
7.81
+0.28(+3.72%)
  • Volume:
    123,102
  • Bid/Ask:
    7.80/7.82
  • Day's Range:
    7.48 - 7.81

IMVT Overview

Prev. Close
7.53
Day's Range
7.48-7.81
Revenue
-
Open
7.53
52 wk Range
6.69-53.61
EPS
-1.27
Volume
123,102
Market Cap
894.7M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
520,303
P/E Ratio
-
Beta
-
1-Year Change
-84.89%
Shares Outstanding
115,000,246
Next Earnings Date
Feb 15, 2022
What is your sentiment on Immunovant Inc?
or
Vote to see community's results!

Immunovant Inc Company Profile

Employees
68

Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops IMVT-1401, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of myasthenia gravis and thyroid eye disease, as well as has completed initiation of Phase II clinical trials for the treatment of warm autoimmune hemolytic anemia. The company is headquartered in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyStrong BuyNeutralSellStrong Sell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong SellStrong Sell
SummaryStrong BuyStrong BuyBuyStrong SellStrong Sell
  • hi
    0
    • https:/ ****benzinga.com/general/biotech/21/08/22272764/immunovant-stock-plunges-on-200m-equity-investment-from-roivant-to-support-imvt-1401-development
      0
      • WHY drop?
        0
        • 10 minuts and we already achieved average volume (3 months) a lot of fear and a lot of greed. Let's see who is right.
          0
          • I bought the dip yesterday at 10,00. Hope it recover soon
            0
            • people its literally on sale
              0
              • Bound to spike back up. It's the year of the bull.
                1
                • what happened?
                  0
                  • what happened?
                    0
                    • Chance of a bid 50:50?
                      0
                      • Chance of a bid from Roivant? 50:50?
                        0
                        • So, will it go up?
                          1
                          • I hope !!!
                            0
                            • Tomorrow skyrocket
                              0
                              • 🚀🚀🚀
                                0
                                • Sell the news
                                  0
                                  • Any idea should I short or keep it?
                                    0
                                    • A lot of good stocks
                                      0
                                  • Going up
                                    0
                                    • Whyyyyy?
                                      0
                                      • https://www.marketwatch.com/story/immunovant-stock-loses-half-its-value-after-pausing-dosing-in-trial-of-thyroid-eye-disease-treatment-2021-02-02
                                        0
                                      • Wertt WerttOkay but it's too much sinking
                                        0
                                    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.